Simple blood test may predict COVID-19 danger in transplant patients

NCT ID NCT04369456

Completed Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a blood sample can predict how severe COVID-19 will become in kidney transplant patients with mild to moderate symptoms. Researchers measured a protein called IL-6 after stimulating the blood sample. They followed 52 patients to see if IL-6 levels were linked to worsening illness, such as needing intensive care. The goal is to find early warning signs to improve patient care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors identify which kidney transplant patients with COVID-19 are at higher risk of severe illness, allowing earlier intervention.
What could go wrong: This is a small, observational study (52 participants) that only looks at biomarkers, not a treatment. The findings may not apply to all patients or lead to direct clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONAVIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Coronavinae infectious disease COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONAVIRUS INFECTION KIDNEY TRANSPLANT; COMPLICATIONS

Contacts and locations

Locations

APHM

Marseille, 13000, France
APHP

Paris, 75000, France
Lyon Univerity Hospital

Lyon, 69000, France
Montpellier University Hospital

Montpellier, 34000, France
Saint Etienne University Hospital

Saint-Etienne, 42000, France
Strasbourg Univeristy Hospital

Strasbourg, 67000, France
University Nice Hospital

Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.